AU3692697A - Patch for transdermal application of pergolid - Google Patents
Patch for transdermal application of pergolidInfo
- Publication number
- AU3692697A AU3692697A AU36926/97A AU3692697A AU3692697A AU 3692697 A AU3692697 A AU 3692697A AU 36926/97 A AU36926/97 A AU 36926/97A AU 3692697 A AU3692697 A AU 3692697A AU 3692697 A AU3692697 A AU 3692697A
- Authority
- AU
- Australia
- Prior art keywords
- pergolid
- patch
- transdermal application
- transdermal
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to a plaster for the transdermal application of pergolide and the pharmaceutically acceptable salts thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19626621 | 1996-07-02 | ||
DE19626621A DE19626621A1 (en) | 1996-07-02 | 1996-07-02 | Plaster for transdermal application of pergolide |
PCT/EP1997/003458 WO1998000142A1 (en) | 1996-07-02 | 1997-07-02 | Plaster for the transdermal application of pergolide |
Publications (3)
Publication Number | Publication Date |
---|---|
AU3692697A true AU3692697A (en) | 1998-01-21 |
AU727267B2 AU727267B2 (en) | 2000-12-07 |
AU727267C AU727267C (en) | 2001-06-28 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
JP2000514053A (en) | 2000-10-24 |
EP0910379A1 (en) | 1999-04-28 |
WO1998000142A1 (en) | 1998-01-08 |
DE59709922D1 (en) | 2003-05-28 |
ES2198584T3 (en) | 2004-02-01 |
DE19626621A1 (en) | 1998-01-08 |
DK0910379T3 (en) | 2003-08-11 |
EP0910379B1 (en) | 2003-04-23 |
ATE238054T1 (en) | 2003-05-15 |
AU727267B2 (en) | 2000-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW350844B (en) | Tricyclic amides useful to inhibition of G-protein function and for treatment of proliferative diseases | |
WO2000057900A3 (en) | Factor for regulation of neurite growth | |
AU1585601A (en) | Transdermal administration of huperzine | |
AU3136897A (en) | Compositions, methods and devices for the transdermal delivery of drugs | |
AU6520499A (en) | Post-operative therapeutic device for amputees | |
AU2466099A (en) | Pharmaceutically active compounds and methods of use thereof | |
AU7070596A (en) | Transdermal administration of olanzapine | |
AU6517196A (en) | Piperazine derivatives as therapeutic agents | |
BG101901A (en) | 2-methyl-thieno-benzodiazepine formulation for oral application | |
AU7031500A (en) | Therapeutic quinazoline compounds | |
AU4477597A (en) | New pharmaceutically active compounds | |
CA2154572A1 (en) | Use of riluzole for the treatment of neuro-sida | |
AU3539297A (en) | Transdermal therapeutic systems | |
AU4345297A (en) | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor | |
AU1429697A (en) | Systems and methods for the transdermal administration of androgenic agents | |
HUP0000445A3 (en) | Flat transdermal medicated self-adhesive patch | |
AU2939897A (en) | Administration of histamine for therapeutic purposes | |
DK0910379T3 (en) | Patch for transdermal application of pergolide | |
AU3869399A (en) | Transdermal administration of fenoldopam | |
AU1068101A (en) | Transdermal administration of reboxetine | |
AU5095698A (en) | Transdermal patch | |
AU8628998A (en) | Dermal adhesive plaster suitable for treating localized cutaneous affections | |
MY133169A (en) | Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect | |
AU6821196A (en) | Transdermal administration of vorozole | |
AU4143397A (en) | New pharmaceutically active compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DA2 | Applications for amendment section 104 |
Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20001204 |
|
FGA | Letters patent sealed or granted (standard patent) | ||
DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20010111 |